Amicus Therapeutics Inc. buy BiotechBee
Start price
13.01.23
/
50%
€11.78
Target price
31.05.24
€17.00
Performance (%)
-9.18%
End price
05.05.23
€10.70
Summary
This prediction ended on 05.05.23 with a price of €10.70. With a performance of -9.18%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amicus Therapeutics Inc. | 0.000% | 0.000% | 35.556% | 7.470% |
| iShares Core DAX® | 0.191% | 4.771% | 20.559% | 64.548% |
| iShares Nasdaq 100 | -0.614% | 3.137% | 5.816% | 110.363% |
| iShares Nikkei 225® | 0.599% | 8.016% | 21.913% | 55.210% |
| iShares S&P 500 | -0.036% | 3.593% | 3.588% | 70.174% |
According to BiotechBee what are the pros and cons of Amicus Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year